IRWD Market Cap | IRONWOOD PHARMACEUTICALS, INC.

IRONWOOD PHARMACEUTICALS INC Market Cap

Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.

IRONWOOD PHARMACEUTICALS INC market cap for the quarter ending 2026-07-31 was $699.79M, a 462.79% increase year-over-year.
IRONWOOD PHARMACEUTICALS INC market cap for the quarter ending 2026-06-30 was $697.31M, a 503.02% increase year-over-year.
IRONWOOD PHARMACEUTICALS INC market cap for the quarter ending 2026-04-30 was $679.85M, a 351.75% increase year-over-year.
IRONWOOD PHARMACEUTICALS INC market cap for the quarter ending 2026-03-31 was $577.79M, a 142.91% increase year-over-year.
IRONWOOD PHARMACEUTICALS INC market cap for fiscal 2026 was $699.79M.
IRONWOOD PHARMACEUTICALS INC market cap for fiscal 2025 was $547.88M, a 22.80% decline from fiscal 2024.
IRONWOOD PHARMACEUTICALS INC market cap for fiscal 2024 was $709.71M, a 60.32% decline from fiscal 2023.
IRONWOOD PHARMACEUTICALS INC market cap for fiscal 2023 was $1.79B, a 6.27% decline from fiscal 2022.

Available history: 2018-12-31 to 2026-07-31
Data captured: 2026-07-31

Historical Market Cap

Date	Market Cap
2026-07-31	$699.79M
2026-06-30	$697.31M
2026-04-30	$679.85M
2026-03-31	$577.79M
2026-01-31	$798.99M
2025-12-31	$547.88M
2025-10-31	$311.53M
2025-09-30	$214.74M
2025-07-31	$124.34M
2025-06-30	$115.64M
2025-04-30	$150.49M
2025-03-31	$237.86M
2025-02-28	$260.51M
2024-12-31	$709.71M
2024-10-31	$632.11M
2024-09-30	$659.27M
2024-07-31	$1.09B
2024-06-30	$1.04B
2024-04-30	$1.23B
2024-03-31	$1.38B
2024-01-31	$2.22B
2023-12-31	$1.79B
2023-10-31	$1.4B
2023-09-30	$1.5B
2023-07-31	$1.73B
2023-06-30	$1.66B
2023-04-30	$1.62B
2023-03-31	$1.63B
2023-01-31	$1.78B
2022-12-31	$1.91B
2022-10-31	$1.68B
2022-09-30	$1.59B
2022-07-31	$1.75B
2022-06-30	$1.77B
2022-04-30	$1.85B
2022-03-31	$1.95B
2022-01-31	$1.78B
2021-12-31	$1.89B
2021-10-31	$2.09B
2021-09-30	$2.13B
2021-07-31	$2.16B
2021-06-30	$2.1B
2021-04-30	$1.79B
2021-03-31	$1.81B
2021-02-10	$1.66B
2020-12-31	$1.83B
2020-11-02	$1.56B
2020-09-30	$1.44B
2020-08-03	$1.57B
2020-06-30	$1.65B
2020-05-01	$1.54B
2020-03-31	$1.61B
2020-02-10	$1.95B
2019-12-31	$2.1B
2019-10-25	$1.43B
2019-09-30	$1.35B
2019-07-26	$1.63B
2019-06-30	$1.71B
2019-04-30	$1.85B
2019-03-31	$1.76B
2019-02-12	$1.71B
2018-12-31	$1.34B

Annual Market Cap

Date	Market Cap
2026-07-31	$699.79M
2025-12-31	$547.88M
2024-12-31	$709.71M
2023-12-31	$1.79B
2022-12-31	$1.91B
2021-12-31	$1.89B
2020-12-31	$1.83B
2019-12-31	$2.1B
2018-12-31	$1.34B

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Nuvectis Pharma, Inc. (NVCT)	United States	$0.705B	-17.53
Climb Bio, Inc. (CLYM)	United States	$0.683B	-13.03
Verastem, Inc. (VSTM)	United States	$0.706B	-1.71
ZEVRA THERAPEUTICS, INC. (ZVRA)	United States	$0.668B	14.61
COLLEGIUM PHARMACEUTICAL, INC (COLL)	United States	$0.737B	24.57
BlossomHill Therapeutics, Inc. (BLSM)	United States	$0.647B
Faeth Therapeutics, Inc. (FTH)	United States	$0.750B
Shattuck Labs, Inc. (STTK)	United States	$0.634B	-13.30
Neurogene Inc. (NGNE)		$0.625B	-4.46
Design Therapeutics, Inc. (DSGN)	United States	$0.766B	-12.78